Skip to main content
Radiolab

Your Friendly Neighborhood Hookworms

46 min episode · 2 min read

Episode

46 min

Read time

2 min

Topics

Health & Wellness, Science & Discovery, Economics & Policy

AI-Generated Summary

Key Takeaways

  • Hygiene Hypothesis: The near-elimination of parasitic worms from Western bodies through modern sanitation may have destabilized immune regulation. Populations in regions where hookworm infections remain common show 50% lower rates of asthma. The absence of worms, not just improved cleanliness, correlates with rising autoimmune disease rates across developed nations.
  • Metabolic Trial Results: In Dr. Jackaman's two-year placebo-controlled trial, prediabetic participants given hookworms showed reduced blood glucose, dramatically lower insulin resistance, and modest weight loss. Some participants moved out of the prediabetic range entirely. Placebo participants showed no such improvements, providing the first causal clinical evidence of worms benefiting metabolic health.
  • Worm Delivery Mechanism: Hookworm larvae are applied via a medicated bandage placed on skin for five minutes. The larvae burrow through skin, travel the lymphatic system, enter the bloodstream, pass through the lungs, get swallowed, and reach the small intestine over two to three weeks — a maturation process that enables gut survival.
  • Immune Modulation Proteins: Once adult hookworms attach to the intestinal wall, they release proteins that suppress immune response and simultaneously promote wound healing at the bite site. Researchers are attempting to isolate and synthesize these proteins into pill form, which could deliver therapeutic benefits without requiring live worm infection in patients.
  • Quality of Life Signal: In two separate placebo-controlled celiac disease trials, participants receiving hookworms reported measurable improvements in mood, well-being, and sleep quality compared to placebo groups. At the conclusion of trials, nearly all participants with worms elected to keep them, suggesting subjective benefit beyond measurable biomarkers alone.

What It Covers

Radiolab revisits its 2009 hookworm episode with a 2024 update from Dr. Paul Jackaman at the Australian Institute of Tropical Health and Medicine, examining clinical trial evidence that hookworm infections may reduce insulin resistance, improve metabolic health, and potentially treat autoimmune conditions including Crohn's disease and celiac disease.

Key Questions Answered

  • Hygiene Hypothesis: The near-elimination of parasitic worms from Western bodies through modern sanitation may have destabilized immune regulation. Populations in regions where hookworm infections remain common show 50% lower rates of asthma. The absence of worms, not just improved cleanliness, correlates with rising autoimmune disease rates across developed nations.
  • Metabolic Trial Results: In Dr. Jackaman's two-year placebo-controlled trial, prediabetic participants given hookworms showed reduced blood glucose, dramatically lower insulin resistance, and modest weight loss. Some participants moved out of the prediabetic range entirely. Placebo participants showed no such improvements, providing the first causal clinical evidence of worms benefiting metabolic health.
  • Worm Delivery Mechanism: Hookworm larvae are applied via a medicated bandage placed on skin for five minutes. The larvae burrow through skin, travel the lymphatic system, enter the bloodstream, pass through the lungs, get swallowed, and reach the small intestine over two to three weeks — a maturation process that enables gut survival.
  • Immune Modulation Proteins: Once adult hookworms attach to the intestinal wall, they release proteins that suppress immune response and simultaneously promote wound healing at the bite site. Researchers are attempting to isolate and synthesize these proteins into pill form, which could deliver therapeutic benefits without requiring live worm infection in patients.
  • Quality of Life Signal: In two separate placebo-controlled celiac disease trials, participants receiving hookworms reported measurable improvements in mood, well-being, and sleep quality compared to placebo groups. At the conclusion of trials, nearly all participants with worms elected to keep them, suggesting subjective benefit beyond measurable biomarkers alone.

Notable Moment

At the end of Dr. Jackaman's two-year diabetes trial, researchers offered participants a standard over-the-counter deworming pill to eliminate their hookworms. Nearly every single participant declined, choosing to keep the worms living inside them — a striking endorsement from people with firsthand experience.

Know someone who'd find this useful?

You just read a 3-minute summary of a 43-minute episode.

Get Radiolab summarized like this every Monday — plus up to 2 more podcasts, free.

Pick Your Podcasts — Free

Keep Reading

Books, tools, and gear mentioned in this episode

SignalCast may earn commission on purchases via these links.

company

More from Radiolab

We summarize every new episode. Want them in your inbox?

Similar Episodes

Related episodes from other podcasts

Explore Related Topics

This podcast is featured in Best Science Podcasts (2026) — ranked and reviewed with AI summaries.

Read this week's Health & Longevity Podcast Insights — cross-podcast analysis updated weekly.

You're clearly into Radiolab.

Every Monday, we deliver AI summaries of the latest episodes from Radiolab and 192+ other podcasts. Free for one show.

Start My Monday Digest

No credit card · Unsubscribe anytime